Equities

Kobayashi Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Kobayashi Pharmaceutical Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)5,635.00
  • Today's Change-74.00 / -1.30%
  • Shares traded175.80k
  • 1 Year change-0.32%
  • Beta0.0544
Data delayed at least 15 minutes, as of Feb 20 2026 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kobayashi Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of healthcare products, daily necessities, and products such as heat packs. The Company operates through two segments including domestic and international. Healthcare products include anmerutsu, eyebon, inochinohaha, naishitoru, and oral hygiene products. Daily necessities include air fresheners/deodorizers, sundries, and food products. The Company also engages in transportation services, the manufacture and sale of synthetic resin containers, real estate management, and advertising planning and production.

  • Revenue in JPY (TTM)165.74bn
  • Net income in JPY3.66bn
  • Incorporated1919
  • Employees3.62k
  • Location
    Kobayashi Pharmaceutical Co LtdKDX Kobayashi Doshomachi Bldg.4-4-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
  • Phone+81 662311144
  • Websitehttps://www.kobayashi.co.jp
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Arata Corp1.00tn8.72bn109.61bn2.92k11.660.83298.070.1096260.70260.7029,905.173,650.052.7715.306.51342,113,200.002.423.265.496.999.689.870.87251.021.1350.940.263427.804.464.370.34887.5711.5719.14
Earth Corp179.18bn5.24bn111.49bn4.88k20.861.4610.780.6222240.61240.618,209.543,429.181.263.367.00--3.924.157.367.8741.7140.813.123.110.8266--0.086751.495.85-1.7850.738.1112.670.8548
Mandom Corp78.24bn2.16bn149.63bn2.59k64.751.9823.411.9147.8847.881,733.441,568.310.81432.407.0630,244,300.002.361.152.991.4546.2443.292.901.543.17--0.0012147.824.03-1.41-28.53-16.00-28.25-8.39
Noevir Holdings Co Ltd63.39bn8.38bn159.17bn1.35k19.003.3516.912.51245.28245.281,855.831,389.760.89632.505.9246,815,360.0012.099.8214.2511.2267.0167.2513.4812.593.52--0.014899.801.414.540.75287.418.862.33
Pigeon Corp109.17bn8.57bn200.36bn3.07k22.992.3814.911.8471.6471.64912.64693.110.99973.595.91--8.098.3710.0210.2750.2348.528.098.613.3346.660.0156108.354.801.902.38-4.24-3.851.09
MTG Co Ltd109.56bn9.50bn213.66bn1.51k22.193.8917.451.95239.75239.752,763.911,369.371.461.977.7972,363,940.0012.507.2717.429.1963.9163.118.586.041.03--0.176613.0837.4923.18248.1439.0738.11--
PALTAC Corp1.23tn21.90bn308.33bn2.28k13.981.0110.900.2512355.75355.7519,935.134,907.792.3016.845.21537,743,700.004.114.387.207.717.537.621.781.841.43--0.0026.623.142.5710.79-2.09-37.948.45
Pola Orbis Holdings Inc170.29bn9.47bn310.48bn4.02k31.691.8417.601.8242.7542.75768.73736.980.85521.939.78--4.765.105.505.8581.2081.975.566.033.37--0.0097111.05-0.0434-0.69312.0015.38-2.160.7875
Kose Holdings Corp330.19bn15.11bn363.62bn8.13k22.661.2112.711.10264.83264.835,785.644,979.350.85041.436.26--4.14--5.33--69.04--4.87--2.47--0.0338--2.30--101.25------
Kobayashi Pharmaceutical Co Ltd165.74bn3.66bn445.59bn3.62k116.082.0135.922.6949.1849.182,229.552,838.340.61313.453.27--1.355.691.697.1151.1154.432.218.932.10--0.003248.940.08581.95-63.68-28.2327.566.20
Lion Corp422.09bn27.59bn501.93bn7.65k18.001.549.621.1999.6899.681,525.161,166.550.8234.255.37--6.055.098.887.7345.9445.997.366.041.47--0.080734.132.223.5030.15-1.58-6.425.46
Shiseido Co Ltd969.99bn-40.68bn1.22tn27.91k--2.0438.311.26-101.83-101.832,427.551,503.640.74641.486.25---3.060.9664-4.391.4176.6073.60-4.101.240.9403--0.3422186.68-2.081.04-276.21---9.580.00
Data as of Feb 20 2026. Currency figures normalised to Kobayashi Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

22.62%Per cent of shares held by top holders
HolderShares% Held
Oasis Management Co. Ltd.as of 22 Dec 202510.19m13.06%
The Vanguard Group, Inc.as of 04 Feb 20261.92m2.46%
Nomura Asset Management Co., Ltd.as of 05 Feb 20261.77m2.27%
Amova Asset Management Co., Ltd.as of 06 Feb 2026803.20k1.03%
Daiwa Asset Management Co. Ltd.as of 30 Jan 2026773.20k0.99%
Norges Bank Investment Managementas of 30 Jun 2025731.24k0.94%
BlackRock Fund Advisorsas of 06 Feb 2026702.50k0.90%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Feb 2026418.00k0.54%
Charles Schwab Investment Management, Inc.as of 05 Feb 2026172.58k0.22%
BlackRock Investment Management (UK) Ltd.as of 31 Dec 2025169.67k0.22%
More ▼
Data from 31 Dec 2025 - 03 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.